Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-20-000274

EVP Strategy and Corporate Dev sold 2,200 shares at an average $411.20 ($904,637)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pacelli Steven Robert EVP Strategy and Corporate Dev 2020-09-30 Sale −1,900 $410.28 $779,527 63,318 D: show line 1 in the form
Pacelli Steven Robert EVP Strategy and Corporate Dev 2020-09-30 Sale −100 $411.10 $41,110 63,218 D: show line 2 in the form
Pacelli Steven Robert EVP Strategy and Corporate Dev 2020-10-01 Sale −200 $420.00 $84,000 63,018 D: show line 3 in the form
Open-market sales · 2,200 sh · avg $411.20 · $904,637
Loading xslF345X03/edgardoc.xml…